Gifts at Changing The Present

Neovista Presents One Year Data on Novel Wet AMD Therapy at ARVO

by (author unknown), Prevent Blindness America Eye Health and Safety News on Jun 23, 2008

Data Analysis Shows Promise of Epiretinal Brachytherapy as NeoVista Progresses with Phase III CABERNET Study.


Be the first to comment on this article.

Add a comment


Please do not include any advertisements or offensive material.



Help Us Stop Spam
To help us prevent spam, please log in or type the two words you see in the box below. This will also help digitize books, one word at a time.

cancel

Support
Changing The Present

Your tax-deductible contribution makes this site possible.

Sponsorships Inquiries
See us on facebook™
Spread the Word
Tell A Friend

Mailing List

GO